MA
BMY icon

MJP Associates’s Bristol-Myers Squibb BMY Stock Holding History

MJP Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Buy
5,086
+139
+3% +$8.1K 0.04% 154
2025
Q4 		$267K Buy
+4,947
New +$238K 0.03% 209
2025
Q2 		– Sell
-3,943
Closed -$240K – 235
2025
Q1 		$240K Buy
+3,943
New +$230K 0.04% 187
2024
Q2 		– Sell
-3,702
Closed -$201K – 238
2024
Q1 		$201K Buy
+3,702
New +$189K 0.04% 221
2023
Q4 		– Sell
-4,985
Closed -$289K – 183
2023
Q3 		$289K Sell
4,985
-2,508
-33% -$154K 0.08% 106
2023
Q2 		$479K Sell
7,493
-853
-10% -$57.2K 0.16% 75
2023
Q1 		$578K Sell
8,346
-25
-0.3% -$1.76K 0.18% 62
2022
Q4 		$602K Buy
8,371
+277
+3% +$20.9K 0.18% 60
2022
Q3 		$575K Sell
8,094
-35
-0.4% -$2.54K 0.17% 58
2022
Q2 		$626K Sell
8,129
-1,393
-15% -$106K 0.18% 61
2022
Q1 		$696K Buy
9,522
+2,289
+32% +$154K 0.17% 60
2021
Q4 		$448K Buy
7,233
+190
+3% +$11.1K 0.13% 83
2021
Q3 		$417K Sell
7,043
-1,530
-18% -$101K 0.14% 80
2021
Q2 		$573K Sell
8,573
-93
-1% -$6.06K 0.19% 61
2021
Q1 		$547K Buy
8,666
+20
+0.2% +$1.24K 0.22% 55
2020
Q4 		$536K Buy
+8,646
New +$532K 0.23% 56

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MJP Associates's BMY Position: Q1 2026 in Review

MJP Associates increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, buying an estimated $8.1K and bringing the position to 5,086 shares worth $308K. The position accounts for 0.04% of the portfolio, ranked #154.

MJP Associates first reported a position in BMY in Q4 2020 and has held it in 16 quarters since. The position peaked at $696K in Q1 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • MJP Associates held 5,086 shares of Bristol-Myers Squibb worth $308K as of Q1 2026.
  • MJP Associates bought 139 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.1K.
  • Bristol-Myers Squibb made up 0.04% of MJP Associates's portfolio in Q1 2026, its #154 holding.
  • MJP Associates first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 16 quarters since.
  • MJP Associates's Bristol-Myers Squibb position peaked at $696K in Q1 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.